Vectors For Gene Delivery
Vectors For Gene Delivery
Vectors For Gene Delivery
Genetic material can be transferred via a vector that is defined as the vehicle that is used to deliver the
gene of interest. The ideal vector would transfer a precise amount of genetic material into each target cell,
thereby allowing for expression of the gene product without causing toxicity.
Gene transfer via the viral vectors is called transduction while transfer via the non‑viral vectors is called
Transfection.
Diagram of the intracytoplasmic injection of a human cell. Micromanipulator on the left holds the
cell in position while microinjector on the right delivers the gene of interest.
A gene gun is used for injecting cells with genetic information, it is also known as biolistic particle
delivery system. Gene guns can be used effectively on most cells but are mainly used on plant cells.
Step 1 The gene gun apparatus is ready to fire. Step 2 When the gun is turned on and the helium
flows through. Step 3 The helium moving the disk with DNA coated particles toward the screen. Step
4 The helium having pushed the particles moving through the screen and moving to the target cells to
transform the cells.
Limitations
low vector titer,
low transfection efficiency,
particle instability
inability to transduce non‑dividing post‑mitotic cells
2. Lentiviruses
3. Adenoviral vectors
DNA viruses
transfer DNA into the nucleus,
no integration
effects are transient (range: 7‑42 days).
Multiple administrations are required.
most cells is susceptible to infection, regardless of
their position in the cell cycle.
higher titer
Limitations
Advantages
ease of purification and concentration and the high efficiency rate of host cell infection
dividing or non‑dividing cells
A good candidate for direct in vivo gene transfer.
Mechanism of adenovirus-mediated delivery of a therapeutic DNA. Upon infection, adenovirus delivers the
encapsulated therapeutic DNA into the cytoplasm of the target cells. Various stages of viral gene
delivery, viz cell attachment, internalization, endocytosis, uncoating, transcription and translation of the
therapeutic protein, are shown.
Limitations
High multiplicity of infection (the number of viral particles per cell required to achieve transduction)
genome is small, only allowing ~4.8 kb of added DNA
5. herpes simplex virus
The advantages of the herpes simplex virus (HSV) are its large size can accommodate large pieces of foreign DNA
The continuous expression of genes from long‑lived infection.
Little risk of insertional mutagenesis with the HSV
because it remains outside the nucleus (episomal).
Ability to remain latent in tissues and to be re‑activated at the original site of infection.
a common pathogen in humans and rarely causes significant illnesses.
Limitations
include low infection efficiency,
large genome size that makes it more difficult to manipulate than other viral vectors.
tropism for neural cells limits its action
6. pox viruses
Limitations
Common toxicities included a local skin reaction at the site of the vaccine
Mild flu‑like symptoms of 1‑2 days’ duration.
Cellular immune response did not correlate with the clinical response.
7. Alpha viruses
Members of the Togaviridae family and are enveloped, single‑stranded RNA viruses
There are three different viruses with similar properties useful in gene therapy: Semliki forest virus, Sindbis virus, and
Venezuelan equine encephalitis virus.
Most alpha virus vectors used as gene vehicles are replication incompetent.
They encode only the non‑structural genes, while the structural genes necessary for replication are located in the helper
plasmid genome.
To eliminate or at least reduce the possibility of generating infectious replication‑competent particles, structural genes
can be localized to two different helper plasmids.
Replication‑competent vectors contain all the genes of the wild‑type genome, including the therapeuticgene, and are
also able to transduce neighboring and surrounding tumor cells.
Because of their extensive host‑cell toxicity and broad host range, alpha viruses are suitable for cancer gene therapy
of various tumors.
Non-viral Vectors
2. DNA vaccination
It is known that bactofection of plasmids encoding a tumor‑expressed antigens can lead to induction of humoral
and cellular immune response in the host thereby providing protective defense against tumors.
This approach, termed DNA vaccination, has been successfully implemented for anti‑angiogenic therapy
3. Alternative gene therapy
4. Bactoference
Bacteria that have engineered to produce and deliver short interfering RNA represent a novel tool for the efficient
induction of RNA interference in host cells.